Koninklijke Philips (PHG) Cash from Investing Activities (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Cash from Investing Activities came in at -$475.3 million in Q1 2026, down 187.82% year-on-year from $541.2 million in Q1 2025, and up 44.59% quarter-over-quarter from -$857.9 million in Q4 2025.
Koninklijke Philips (PHG) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Koninklijke Philips' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$475.3 million for Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 187.82% year-over-year to -$475.3 million in Q1 2026; TTM through Mar 2026 was -$2.2 billion, a 33.6% decrease from a year earlier, with the FY2025 full-year figure at -$857.9 million, down 40.11% from the prior year.
- Cash from Investing Activities climbed to -$475.3 million in Q1 2026 per PHG's latest filing, from -$857.9 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$165.1 million in Q1 2025 and bottomed at -$1.5 billion in Q4 2022.
- The 5-year median for Cash from Investing Activities is -$520.6 million (2024), against an average of -$584.7 million.
- Across the five-year window, Cash from Investing Activities surged 75.77% in 2022 and slumped 187.82% in 2026, its largest moves.
- Year by year, Cash from Investing Activities stood at -$1.5 billion in 2022, then soared by 54.89% to -$684.3 million in 2023, then grew by 10.52% to -$612.3 million in 2024, then slumped by 40.11% to -$857.9 million in 2025, then surged by 44.59% to -$475.3 million in 2026.
- Per Business Quant, the three latest PHG Cash from Investing Activities figures stand at -$475.3 million (Q1 2026), -$857.9 million (Q4 2025), and -$632.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | -298.50 Mn |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Steris | 21.43 Bn | 20.99 Bn | 697.10 Mn | -217.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -475.32 Mn |
| Mar 31, 2026 | -475.32 Mn |
| Dec 31, 2025 | -857.90 Mn |
| Dec 31, 2025 | -857.90 Mn |
| Sep 30, 2025 | -632.46 Mn |
| Sep 30, 2025 | -632.46 Mn |
| Jun 30, 2025 | -254.69 Mn |
| Jun 30, 2025 | -254.69 Mn |
| Mar 31, 2025 | -165.15 Mn |
| Mar 31, 2025 | -165.15 Mn |
| Dec 31, 2024 | -612.31 Mn |
| Dec 31, 2024 | -612.31 Mn |
| Sep 30, 2024 | -520.56 Mn |
| Sep 30, 2024 | -520.56 Mn |
| Jun 30, 2024 | -363.99 Mn |
| Jun 30, 2024 | -363.99 Mn |
| Mar 31, 2024 | -190.11 Mn |
| Mar 31, 2024 | -190.11 Mn |
| Dec 31, 2023 | -684.30 Mn |
| Dec 31, 2023 | -684.30 Mn |